Serum prostate-specific antigen after radiation therapy for clinically localized prostate cancer: Prognostic implications
- 30 September 1994
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 30 (2) , 279-287
- https://doi.org/10.1016/0360-3016(94)90005-1
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The serum prostate-specific antigen level three months after radiotherapy for prostate cancer: an early indicator of response to treatmentRadiotherapy and Oncology, 1994
- The prognostic significance of a single serum prostate-specific antigen value beyond six months after radiation therapy for adenocarcinoma of the prostateInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Is Prostate Specific Antigen of Clinical Importance in Evaluating Outcome after Radical ProstatectomyJournal of Urology, 1993
- Prostate-specific antigen as a prognostic factor for prostate cancer treated by external beam radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Serum prostate-specific antigen in monitoring the response of carcinoma of the prostate to radiation therapyRadiotherapy and Oncology, 1992
- A model of prostatic carcinoma tumor kinetics based on prostate specific antigen levels after radiation therapyCancer, 1991
- A prospective study of prostate specific antigen levels in patients receiving radiotherapy for localized carcinoma of the prostateInternational Journal of Radiation Oncology*Biology*Physics, 1990
- Effect of external beam radiation therapyon serum prostate-specific antigenUrology, 1990
- Prostatc specific antigen as an indicator of response to radiotherapy in prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Prostate Specific Antigen in the Preoperative and Postoperative Evaluation of Localized Prostatic Cancer Treated with Radical ProstatectomyJournal of Urology, 1988